SABCS

Clinically focused coverage from the San Antonio Breast Cancer Symposium, highlighting key data.

TNBC

Browse all TNBC

TNBC

Adjuvant Carboplatin and PARP Inhibitor Combination Trials in TNBC

Rebecca Shatsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

TNBC

Impact of ADCs in Early TNBC Treatment

Mariam Haji Ahmad, MBBCh, Alexis Levee, MD

TNBC

ADCs in TNBC: Current Data and Unanswered Questions

Pietro De Placido, MD, Dionisia Quiroga, DO, PhD, FASCO

TNBC

Anti-TROP-2 ADCs in PD-L1-Negative TNBC

Alexis Levee, MD, Paolo Tarantino, MD

HER2-POSITIVE BREAST CANCER

Browse all HER2-POSITIVE BREAST CANCER

HER2-POSITIVE BREAST CANCER

4 Significant Trials for HER2+ Breast Cancer at SABCS 2025

Harold Burstein, MD, PhD, Rohit Gosain, MD, Rahul Gosain, MD, MBA

HER2-POSITIVE BREAST CANCER

The Evolving Role of T-DXd Across HER2+ Breast Cancer

Yash Agrawal, MD, Stephanie Graff, MD, FACP, FASCO

HER2-POSITIVE BREAST CANCER

Emerging Roles of Biomarkers in HER2-Positive Breast Cancer

Yash Agrawal, MD, Madison Canning, MD

HER2-POSITIVE BREAST CANCER

De-escalation and Sequencing Strategies Shape HER2-Positive Breast Cancer Care at SABCS 2025

Nerea Lopetegui-Lia, MD, Ya Haddy Sallah, MD, MPH

HR+ DISEASE

Browse all HR+ DISEASE

HR+ DISEASE

HR+ Metastatic Breast Cancer Updates from SABCS 2025

Hope Rugo, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

HR+ DISEASE

SABCS 2025 Updates on Inavolisib and Giredestrant in Breast Cancer

Tyler Kristoff, MD, Sarah Premji, MD

HR+ DISEASE

Key HR+, Early Breast Cancer Abstracts From SABCS 2025

Laura Huppert, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

HR+ DISEASE

Patient Advocacy Brings Breast Cancer Vaccine to Phase 1 Trial

Judy Fitzgerald, Karissa Britten, MD